| 國立成功大學 |
2009 |
At the Cutting Edge: Ghrelin Gene Products in Food Intake and Gut Motility
|
Chen, Chih-Yen; Fujimiya, Mineko; Asakawa, Akihiro; Chang, Full-Young; Cheng, Juei-Tang; Lee, Shou-Dong; Inui, Akio |
| 國立成功大學 |
2013-12-11 |
At the frontiers of high-resolution hard-x-ray microscopy: an international programme
|
Wu, S. R.; Lin, C. H.; Chen, Y. S.; Chen, Y. Y.; Hwu, Y.; Chu, Y. S.; Margaritondo, G. |
| 國立臺灣海洋大學 |
2013-12 |
At the frontiers of high-resolution hard-x-ray microscopy: an international programme
|
G. Margaritondo; S. R. Wu; C. H. Lin; Y. S. Chen; Y. Y. Chen; Y. Hwu; Y. S. Chu |
| 臺大學術典藏 |
2000-10 |
At the Intersection of the Global and the Local: Representations of Male Homosexuality in Fictions by Pai Hsien-yung, Li Ang, Chu Tien-wen, and Chi Ta-wei
|
劉亮雅; 劉亮雅 |
| 國立臺灣大學 |
2003 |
At the Intersection of the Global and the Local: Representations of Male Homosexuality in Fictions by Pai Hsien-yung, Li Ang, Chu Tien-wen, and Chi Ta-wei
|
Liou, Liang-ya |
| 國立臺灣大學 |
2000-10 |
At the Intersection of the Global and the Local: Representations of Male Homosexuality in Fictions by Pai Hsien-yung, Li Ang, Chu Tien-wen, and Chi Ta-wei
|
劉亮雅 |
| 佛光大學 |
2009-05-27 |
At the Junction of Continental and Maritime Trading Networks : Taiwan and the VOC During the 17th Century
|
林錚 |
| 中國文化大學 |
2023-08 |
At the Subtle Crevice of Contested Inter-counter Connections among Confucianism, Buddhism, and Daoism: The Politics of Gender/Sexual Shamelessness among Contemporary Chinese Yaos
|
林純德 |
| 臺大學術典藏 |
2022-05-24T06:20:47Z |
At what data length do cerebral autoregulation measures stabilise?
|
Mahdi A.;Nikolic D.;Birch A.A.;Payne S.J.; Mahdi A.; Nikolic D.; Birch A.A.; Payne S.J.; STEPHEN JOHN PAYNE |
| 國立成功大學 |
2015-10 |
At will or not at will: Electrophysiological correlates of preparation for voluntary and instructed task-switching paradigms
|
Chen, Poyu; Hsieh, Shulan |
| 國立臺灣體育運動大學 |
1989-05-02 |
AT&T網球賽 再遇剋星 張德培亞軍 稱讚阿格西打得好 往後的比賽有信心/天才之技 論張德培的球藝 馬克安諾的教練柯漢 在世界網球雜誌撰文 足以讓人一窺張德培撂倒名將的風貌……
|
劉延青 |
| 國立成功大學 |
2020-01-20 |
AT-3型機起落架減震支柱輕量化
|
吳鎮宇; Wu, Cheng-Yu |
| 國立成功大學 |
2019-12-24 |
AT-3型機起落架減震支柱輕量化
|
吳鎮宇; Wu, Cheng-Yu |
| 國立中山大學 |
2000 |
AT1及AT2接受器參與血管張力素抑制感壓反射作用之機轉研究(III)
|
陳慶鏗; Samuel H.H. Chan |
| 建國科技大學 |
2004 |
AT89S51/52 燒錄模擬器之設計
|
薛棟樑;羅榮村; Shiue Dong-Liang;Lou Rong-Tsuen |
| 國立臺灣科技大學 |
2003 |
ATA-based硬碟之效能監測系統之設計與實現
|
王佳 |
| 國立臺灣大學 |
1991 |
Ataxia-Telangiectasia Associated with Torticollis:Report of One Case
|
王本榮; Chu, J. M.; Tsai, Y. T.; Hseih, K. H.; Wang, Pen-Jung; Chu, J. M.; Tsai, Y. T.; Hseih, K. H. |
| 臺大學術典藏 |
2017 |
Ataxia-telangiectasia mutated interactor regulates head and neck cancer metastasis via KRas expression
|
Lin, Been-Ren; Chen, Szu-Ta; Wu, Tai-Sheng; Cheng, Shih-Jung; Yang, Cheng-Ning; DENG, YI-TING; Kuo, Mark Yen-Ping; Chang, Cheng-Chi; WANG-TSO LEE; Li, Yue-Ju;Wang-Tso Lee;Chang, Cheng-Chi;Kuo, Mark Yen-Ping;Deng, Yi-Ting;Yang, Cheng-Ning;Cheng, Shih-Jung;Wu, Tai-Sheng;Chen, Szu-Ta;Lin, Been-Ren; Li, Yue-Ju |
| 臺大學術典藏 |
2021-07-05T05:41:55Z |
Ataxia-telangiectasia mutated interactor regulates head and neck cancer metastasis via KRas expression
|
Li Y.-J.; Lai W.-T.; Chang C.-C.; YEN-PING KUO; Deng Y.-T.; Yang C.-N.; Cheng S.-J.; Wu T.-S.; Chen S.-T.; Lin B.-R. |
| 臺大學術典藏 |
2021-07-07T03:41:13Z |
Ataxia-telangiectasia mutated interactor regulates head and neck cancer metastasis via KRas expression
|
Li Y.-J.; Lai W.-T.; Chang C.-C.; Kuo M.Y.-P.; Deng Y.-T.; Yang C.-N.; SHIH-JUNG CHENG; Wu T.-S.; Chen S.-T.; Lin B.-R. |
| 國立成功大學 |
2022 |
Ataxin-3蛋白表現在泌尿上皮癌的臨床意義
|
蔡育賢 |
| 國立成功大學 |
2021 |
Ataxin-3蛋白表現在泌尿上皮癌的臨床意義
|
蔡育賢 |
| 國立成功大學 |
2023 |
Ataxin-3蛋白表現在泌尿上皮癌的臨床意義
|
蔡育賢 |
| 國立臺灣師範大學 |
2014-10-27T15:41:56Z |
Atayal Myths
|
黃美金 |
| 國立臺灣師範大學 |
2015-01-29T09:15:36Z |
Atayal Reduplication and Its Interface with Phonology
|
林蕙珊 |
| 慈濟大學 |
2006 |
AtBAG-4在光敏素的訊息傳遞中所扮演的角色
|
鄭凱鴻 |
| 慈濟大學 |
2009 |
AtBAG4在種子及果實發育中所扮演的角色
|
林怡萱 |
| 朝陽科技大學 |
2018-05-31 |
ATC-水中運動椅
|
林志旻 |
| 國立交通大學 |
2014-12-12T02:29:34Z |
ATC公司在中國大陸研發投資之個案研究
|
溫斯成; Szu-Cheng Wen; 王 克 陸; Kehluh Wang |
| 元培科技大學 |
2009-04-24 |
Ate pairing效能改進之研究
|
林志賢 |
| 國立成功大學 |
2014-01 |
Atectonic Expression from Theory to Practice: From Semper's Bekleidung to Empirical Projects
|
Wu, Nan-Wei; Fu, Chao-Ching |
| 臺大學術典藏 |
2021-07-15T05:31:34Z |
Atelocollagen-embedded chondrocyte precursors as a treatment for grade-4 cartilage defects of the femoral condyle: A case series with up to 9-year follow-up
|
Liu, Hwa Chang; Liu, Tzu Shang Thomas; Liu, Yen Liang; JYH-HORNG WANG; Chang, Chih Hung; TIFFANY TING-FANG SHIH; Lin, Feng-Huei |
| 臺大學術典藏 |
2021-12-16T03:41:34Z |
Atelocollagen-Embedded Chondrocyte Precursors as a Treatment for Grade-4 Cartilage Defects of the Femoral Condyle: A Case Series with up to 9-Year Follow-Up
|
Liu, Hwa-Chang; Liu, Tzu-Shang Thomas; Liu, Yen-Liang; Wang, Jyh-Horng; Chang, Chih-Hung; TIFFANY TING-FANG SHIH; Lin, Feng-Huei |
| 臺大學術典藏 |
2022-03-22T08:28:54Z |
Atelocollagen-embedded chondrocyte precursors as a treatment for grade-4 cartilage defects of the femoral condyle: A case series with up to 9-year follow-up
|
Liu H.-C;Liu T.-S.T;Liu Y.-L;Wang J.-H;Chang C.-H;Shih T.T.-F;Lin F.-H.; Liu H.-C; Liu T.-S.T; Liu Y.-L; Wang J.-H; Chang C.-H; Shih T.T.-F; Lin F.-H.; FENG-HUEI LIN |
| 臺大學術典藏 |
2022-03-22T08:32:04Z |
Atelocollagen-embedded chondrocyte precursors as a treatment for grade-4 cartilage defects of the femoral condyle: A case series with up to 9-year follow-up
|
Liu H.-C;Liu T.-S.T;Liu Y.-L;Wang J.-H;Chang C.-H;Shih T.T.-F;Lin F.-H.; Liu H.-C; Liu T.-S.T; Liu Y.-L; Wang J.-H; Chang C.-H; Shih T.T.-F; Lin F.-H.; FENG-HUEI LIN |
| 臺大學術典藏 |
2022-03-22T08:31:57Z |
Atelocollagen-embedded chondrocyte precursors as a treatment for grade-4 cartilage defects of the femoral condyle: A case series with up to 9-year follow-up
|
Liu H.-C;Liu T.-S.T;Liu Y.-L;Wang J.-H;Chang C.-H;Shih T.T.-F;Lin F.-H.; Liu H.-C; Liu T.-S.T; Liu Y.-L; Wang J.-H; Chang C.-H; Shih T.T.-F; Lin F.-H.; FENG-HUEI LIN |
| 臺大學術典藏 |
2021-08-10T03:37:24Z |
Atelocollagen-Embedded Chondrocyte Precursors as a Treatment for Grade-4 Cartilage Defects of the Femoral Condyle: A Case Series with up to 9-Year Follow-Up
|
Liu, Hwa-Chang; Liu, Tzu-Shang Thomas; Liu, Yen-Liang; JYH-HORNG WANG; Chang, Chih-Hung; Shih, Tiffany Ting-Fang; Lin, Feng-Huei |
| 國立臺灣大學 |
1952 |
Atempt to Synthesige 5.6.7.8.2'.3'.4'.5'.6'-Nonahydroxyflavone
|
廖宗凱 |
| 臺北醫學大學 |
1994 |
Atenolol前驅藥之製備研究
|
林友慈 |
| 臺北醫學大學 |
2004 |
Atenolol與Carvedilol於高血壓大白鼠大動脈內皮細胞隙連結之差異性作用
|
李秉穎; Ping-Ying Lee |
| 國立臺灣大學 |
2010 |
AtERF1及AIL7在非生物性逆境耐受性上分別扮演的角色
|
郭瑋文; Kuo, Wei-Wen |
| 朝陽科技大學 |
2022-12-09 |
ATERRA
|
陳奕如;潘妏婷;李岱樺;蔡宜軒;張雨薇;黃沛儒 |
| 臺大學術典藏 |
2021-08-31T06:29:15Z |
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma. Reply
|
Finn R.S.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-14T23:18:53Z |
Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance
|
Wang, Yulei; Lu, Li Chun; Guan, Yinghui; MING-CHIH HO; Lu, Shan; Spahn, Jessica; CHIH-HUNG HSU |
| 臺大學術典藏 |
2022-02-07T03:29:02Z |
Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance
|
Wang Y.; Lu L.-C.; Guan Y.; Ho M.-C.; Lu S.; Spahn J.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2021-11-25T02:38:28Z |
Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance
|
Wang, Yulei; Lu, Li-Chun; Guan, Yinghui; MING-CHIH HO; Lu, Shan; Spahn, Jessica; Hsu, Chih-Hung |
| 國家衛生研究院 |
2021-07 |
Atezolizumab plus bevacizumab for patients with advanced hepatocellular carcinoma and chronic hepatitis B virus infection with high viral load
|
Chen, S;Lai, H;Tsou, H;Shao, Y;Chang, C;Su, T;Liu, T;Chen, L;Cheng, A;Hsu, C |
| 國家衛生研究院 |
2023-06 |
Atezolizumab plus bevacizumab for patients with unresectable hepatocellular carcinoma and high hepatitis B viral load: Focusing on hepatic safety and viral kinetics
|
Chen, SC;Tsou, HHS;Lee, TY;Wang, HW;Chen, YH;Wang, TE;Su, YY;Yang, S;Chiu, CF;Liu, TW;Cheng, AL;Chen, LT;Hsu, C |
| 臺大學術典藏 |
2021-08-31T06:29:17Z |
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
|
Finn R.S.; Qin S.; Ikeda M.; Galle P.R.; Ducreux M.; Kim T.-Y.; Kudo M.; Breder V.; Merle P.; Kaseb A.O.; Li D.; Verret W.; Xu D.-Z.; Hernandez S.; Liu J.; Huang C.; Mulla S.; Wang Y.; Lim H.Y.; Zhu A.X.; ANN-LII CHENG; IMbrave150 Investigators |
| 臺大學術典藏 |
2022-02-21T02:04:35Z |
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study
|
Qin S.; Ren Z.; Feng Y.-H.; Yau T.; Wang B.; Zhao H.; Bai Y.; Gu S.; Li L.; Hernandez S.; Xu D.-Z.; Mulla S.; Wang Y.; Shao H.; ANN-LII CHENG |
